Mark L. Alley

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Cipher Surgical Ltd. designs and develops laparoscopic medical devices. It offers OpClear, which is a sterile disposable unit that provides intra-abdominal solution for distal window contamination for the entire laparoscopic procedure. The company was founded by Andrew Newell, Simon Timothy James Ratcliffe and Neil Roderick Walmsley on May 18, 2010 and is headquartered in Coventry, the United Kingdom.